Ameriprise’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.64M Buy
284,245
+1,658
+0.6% +$36K ﹤0.01% 2240
2025
Q4
$5.94M Buy
282,587
+187,144
+196% +$3.26M ﹤0.01% 2313
2025
Q3
$1.47M Sell
95,443
-1,231
-1% -$16.1K ﹤0.01% 3167
2025
Q2
$905K Buy
96,674
+62,446
+182% +$687K ﹤0.01% 3311
2025
Q1
$420K Buy
34,228
+2,246
+7% +$31.7K ﹤0.01% 3558
2024
Q4
$423K Sell
31,982
-454,246
-93% -$7.77M ﹤0.01% 3587
2024
Q3
$9.36M Sell
486,228
-34,852
-7% -$720K ﹤0.01% 1851
2024
Q2
$10.7M Buy
521,080
+9,579
+2% +$200K ﹤0.01% 1686
2024
Q1
$12.2M Buy
511,501
+5,492
+1% +$122K ﹤0.01% 1614
2023
Q4
$10.9M Buy
506,009
+6,488
+1% +$99.7K ﹤0.01% 1697
2023
Q3
$7.25M Buy
499,521
+143,600
+40% +$2.72M ﹤0.01% 1982
2023
Q2
$7.45M Buy
+355,921
New +$7.41M ﹤0.01% 2034
2022
Q4
Sell
-276,731
Closed -$6.65M 4041
2022
Q3
$6.65M Buy
+276,731
New +$6.21M ﹤0.01% 2014
2020
Q3
Sell
-10,900
Closed -$162K 3778
2020
Q2
$162K Sell
10,900
-20,900
-66% -$318K ﹤0.01% 3528
2020
Q1
$349K Buy
+31,800
New +$298K ﹤0.01% 3254

Other funds holding SNDX